Synonyms:5-BROMO-2'-DEOXYURIDINE, 59-14-3, Broxuridine, Bromodeoxyuridine, 5-Bromodeoxyuridine, 5-BrdU, BRDU, BUDR, 5-Bromouracil deoxyriboside, Bromouracil deoxyriboside, 5-Bromodesoxyuridine, 5-Bdu, Broxuridinum, 5-Bromo-2-deoxyuridine, Broxuridina, 5-Bromouracil-2-deoxyriboside, C9H11BrN2O5, NSC-38297, Uridine, 5-bromo-2'-deoxy-, CHEBI:472552, CHEMBL222280, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, DTXSID7033105, 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, G34N38R2N1, 5-Bromo-2'-deoxyuridine (BRDU), NCGC00090770-05, MFCD00006529, 5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione, Broxuridine [INN], DTXCID5013105, Broxuridinum [INN-Latin], BDU, Broxuridina [INN-Spanish], CAS-59-14-3, SMR001227189, bromodeoxyuridine (brdu), CCRIS 818, HSDB 7477, Broxuridine [INN:JAN], EINECS 200-415-9, (+)-5-Bromo-2'-deoxyuridine, BRN 0030395, UNII-G34N38R2N1, 5-Bromo-2'-deoxyuridine(BRDU), 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione, 5-Bromo-dURD, 5-brom-2'-desoxyuridin, Broxuridine (JAN/INN), BROXURIDINE [MI], Maybridge4_003385, BROXURIDINE [JAN], BROXURIDINE [HSDB], Epitope ID:138105, 5-bromo-2'-deoxy uridine, cid_6035, BROXURIDINE [MART.], Lopac0_000212, SCHEMBL27755, BROXURIDINE [WHO-DD], 4-24-00-01234 (Beilstein Handbook Reference), MLS001055406, MLS002153366, 5-Bromo-2'-deoxyuridine, 97%, HMS1619B05, HMS3039G15, HMS3260L05, BCP21681, 5-BROMO-2''-DEOXY URIDINE, Tox21_111016, Tox21_200106, Tox21_500212, BDBM50207303, HB0979, HG1160, STL530083, AKOS001715166, AKOS016015753, AKOS037495737, Tox21_111016_1, CCG-204307, DB12028, LP00212, SDCCGSBI-0050200.P002, BrdU (5-Bromo-2′-deoxyuridine), NCGC00090770-01, NCGC00090770-02, NCGC00090770-03, NCGC00090770-04, NCGC00090770-06, NCGC00090770-07, NCGC00090770-08, NCGC00090770-09, NCGC00090770-14, NCGC00175901-01, NCGC00257660-01, NCGC00260897-01, 1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihydropyrim idine-2,4-dione, 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione, AS-11762, BP-58665, HY-15910, 5-Bromo-2'-deoxyuridine, >=99% (HPLC), B1575, EU-0100212, 5-Bromo-2'-deoxyuridine, BioUltra, >=99%, 5-Bromo-2'-deoxyuridine, >=99.0% (HPLC), B 5002, D01763, 5- Br-2 inverted exclamation mark -deoxyuridine, EN300-7376709, Q419861, SR-01000075718, J-700086, SR-01000075718-1, Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone, (+)-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]- pyrimidine-2,4-dione, 5-bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxypyrimidin-2(1H)-one, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Id:6035
Description:nan